Profile
Yvonne Engelen started her career as assistant professor at the Eindhoven University of Technology in the Netherlands.
After a few years as at this University, she joined DSM and filled positions in internal R&D management, commercial R&D management and corporate recruitment.
Currently, Yvonne is the Investment Manager for DSM's Corporate Venturing group.
Yvonne has a M.Sc.
degree in Chemical Engineering and a PhD in Polymer Technology both from the Eindhoven University of Technology in the Netherlands.
Former positions of Yvonne Engelen
| Companies | Position | End |
|---|---|---|
DSM Venturing BV
 DSM Venturing BV Investment ManagersFinance DSM Venturing BV (DSM Venturing) is the venture capital arm of Royal DSM NV in the Netherlands founded in 2001. DSM Venturing BV is headquartered in Geleen. | Director/Board Member | 2012-03-30 |
Sciona, Inc.
 Sciona, Inc. Pharmaceuticals: MajorHealth Technology Sciona, Inc. provides health and nutrition recommendations. It researches and develops DNA screens for common gene variants that affect an individual's response to food, medications and the environment. These genetic screens serve as the basis for providing personalized advice to consumers. The company was founded by Rosalynn Gill-Garrison and Gareth Roberts on June 8, 2000 and is headquartered in Boulder, CO. | Director/Board Member | 2010-01-24 |
Jurilab Oy
 Jurilab Oy Pharmaceuticals: MajorHealth Technology Jurilab Oy provides research and development services. The firm offers pharmacokinetic tests, genotyping services, drug target discovery and Phenotype and target validation services. The company was founded in 1999 and is headquartered in Kuopio, Finland. | Director/Board Member | 2009-05-13 |
| SOL-GEL TECHNOLOGIES LTD. | Director/Board Member | - |
Upfront Chromatography A/S
 Upfront Chromatography A/S Miscellaneous Commercial ServicesCommercial Services Upfront Chromatography A/S develops a customized protein separation process. The firm offers industrial-scale customized separation solutions to isolate and purify soluble proteins from industrial process streams. Its core protein purification technology, rhobust, is applicable to industrial feed stocks. The company was founded by Allan Otto Fog Lihme in 1992 and is headquartered in Copenhagen, Denmark. | Director/Board Member | - |
Training of Yvonne Engelen
| Technische Universiteit Eindhoven | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SOL-GEL TECHNOLOGIES LTD. | Health Technology |
| Private companies | 4 |
|---|---|
Sciona, Inc.
Sciona, Inc. Pharmaceuticals: MajorHealth Technology Sciona, Inc. provides health and nutrition recommendations. It researches and develops DNA screens for common gene variants that affect an individual's response to food, medications and the environment. These genetic screens serve as the basis for providing personalized advice to consumers. The company was founded by Rosalynn Gill-Garrison and Gareth Roberts on June 8, 2000 and is headquartered in Boulder, CO. | Health Technology |
DSM Venturing BV
DSM Venturing BV Investment ManagersFinance DSM Venturing BV (DSM Venturing) is the venture capital arm of Royal DSM NV in the Netherlands founded in 2001. DSM Venturing BV is headquartered in Geleen. | Finance |
Upfront Chromatography A/S
Upfront Chromatography A/S Miscellaneous Commercial ServicesCommercial Services Upfront Chromatography A/S develops a customized protein separation process. The firm offers industrial-scale customized separation solutions to isolate and purify soluble proteins from industrial process streams. Its core protein purification technology, rhobust, is applicable to industrial feed stocks. The company was founded by Allan Otto Fog Lihme in 1992 and is headquartered in Copenhagen, Denmark. | Commercial Services |
Jurilab Oy
Jurilab Oy Pharmaceuticals: MajorHealth Technology Jurilab Oy provides research and development services. The firm offers pharmacokinetic tests, genotyping services, drug target discovery and Phenotype and target validation services. The company was founded in 1999 and is headquartered in Kuopio, Finland. | Health Technology |
- Stock Market
- Insiders
- Yvonne Engelen
